MYOCURE partners contribute to success of the first Spring School of the ESGCT
The first Spring School of the European Society for Gene and Cell Therapy (ESGCT) took place in Hannover from April 20-22, 2016. The event was organized in cooperation with the German Society for Gene and Cell Therapy (DG-GT), German Center for Infection Research (DZIF) and Hannover Medical School (MHH).
Participants of the Spring School benefitted from an intensive three-day training course with leading researchers from the field of Gene and Cell Therapy including potential internships, debates and networking opportunities.
The MYOCURE partners Vrije Universiteit Brussel (VUB) and Heidelberg University (UKL-HD) contributed to the programme by presenting insights into their work. The MYOCURE coordinator Prof. Dr. Marinee Chuah was invited as a speaker to give a talk entitled "Next generation cardiac and skeletal muscle-directed gene therapy using tissue specific transcriptional modules identified by genome-wide computational analysis.” In this context, Prof. Chuah also introduced the goal and objectives of MYOCURE to the audience. In addition, MYOCURE partner Dr. Dirk Grimm (UKL-HD) gave a talk on “Vectorizing genetic engineering tools”.
The ESGCT is committed to support scientists and clinicians with basic and translational research on gene transfer and clinical applications of gene and cell therapy. MYOCURE and the ESGCT share the common interest to develop effective new treatments to alleviate human inherited and acquired diseases.
Check out the Spring School website to find more information.